Foundayo was approved in the U.S. on April 1, with prescriptions accepted immediately on LillyDirect, while shipping started ...

The study found 4% of users reported "menstrual irregularities," according to Neil Sehgal, the study's first author.

In animal studies, an experimental drug targeting both GIP and glucagon led to equal or greater weight loss compared to ...

A study in Nature found a specific genetic variant that may boost the effectiveness of GLP-1 weight-loss drugs like ...

By Nancy Lapid April 16 (Reuters) - Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo ...

The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in ...

Two years ago, Sue Prentiss got a sobering reality check at her doctor’s office. The news was blunt: She qualified for bariatric surgery, a procedure for patients whose weight poses life-threatening ...

More patients on Eli Lilly’s tirzepatide lost over 5% of their lean mass versus those on Novo Nordisk’s semaglutide, ...

Weight-loss drugs may eventually reach only about 50% of the overweight and obese people who could benefit from them due to ...

CNN political commentator Scott Jennings has undergone a substantial lifestyle overhaul, losing nearly 100lbs - and a Harvard ...